Contract notice
Section I: Contracting
authority
I.1) Name and addresses
MHRA Buyer Organisation
London
UK
Telephone: +44 2030806000
E-mail: Kash.Ahmed@mhra.gov.uk
NUTS: UK
Internet address(es)
Main address: https://mhra.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.3) Communication
Access to the procurement documents is restricted. Further information can be obtained at:
https://mhra.bravosolution.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent electronically to:
https://mhra.bravosolution.co.uk
Tenders or requests to participate must be sent to the abovementioned address
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
SafetyConnect
II.1.2) Main CPV code
48000000
II.1.3) Type of contract
Supplies
II.1.4) Short description
This procurement forms part of the SafetyConnect Programme which is a technology enabled strategic business change programme that aims to significantly enhance the UK’s vigilance capability. As part of the SafetyConnect Programme, the MHRA are looking to replace its signal detection and management information technology systems used in its pharmacovigilance and medical product vigilance (medical devices, in vitro diagnostics and Haemovigilance) activities.
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
This procurement forms part of the SafetyConnect Programme which is a technology enabled strategic business change programme that aims to significantly enhance the UK’s vigilance capability. As part of the SafetyConnect Programme, the MHRA are looking to replace its signal detection and management information technology systems used in its pharmacovigilance and medical product vigilance (medical devices, in vitro diagnostics and Haemovigilance) activities.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 84
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Competitive procedure with negotiation
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
30/11/2020
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.4) Procedures for review
VI.4.1) Review body
Medicines and Healthcare products Regulatory Agency
London
UK
VI.5) Date of dispatch of this notice
05/10/2020